8-K Karyopharm Therapeutics Inc. 2026-08-31: filing_items
| Value | {"items": {"8.01": "Other Events"}, "value": "8.01"} |
|---|---|
| Period | (as of 2026-08-31) |
| Status | current |
| Entity | 8-K Karyopharm Therapeutics Inc. 2026-08-31 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1503802/000119312526375495/0001193125-26-375495-in
Retrieved: 2026-08-31T14:21:54.644051+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/f6c8edea-0fec-424c-b386-8b7028c93045
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1503802/000119312526375495/0001193125-26-375495-in
Retrieved: 2026-08-31T14:21:54.644051+02:00
Raw response sha256:
930bc1983c1ff11c48f0d5078f2104e0…Cite as: FACTANKER, https://factanker.com/fact/f6c8edea-0fec-424c-b386-8b7028c93045
History
- no predecessors — first report